Metabolic dysfunction asociated steatotic liver disease prevalence is 25%world wide diabetic patients have a risk for MASLD then have hepatic fibrosis so we study correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic fibrosis In Metabolic dysfunction asociated steatotic liver disease in patients with type2 Diabetes Mellitus
Study Type
OBSERVATIONAL
Enrollment
80
corrolation between serum adiponectin and Resistin levels and degree of hepatic fibrosis
hepatic fibrosis detection in type 2 diabetes mellutis
degree of hepatic fibrosis in MASLD with type 2 diabetes mellitus
adiponectineand resistine level with degree of hepatic fibrosis in MASLD pt. with type 2 DM
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.